The growing pots of money held by VCs is starting to flow more into deals, which will help support future growth. Inc.com reports:
"Overall investment by venture capitalists is up 19% from last year, up from $14.1 billion to $16.8 billion....Biotechnology and telecommunication companies led by companies like Avera Pharmaceuticals and Vonage Holdings attracted the most attention from the venture capital community, though semiconductor manufacturers and companies addressing computer-security concerns were also popular with speculators."
